Tevogen (TVGN) Other Working Capital Changes (2022 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Other Working Capital Changes came in at -$28781.0 in Q1 2026, up 55.04% YoY from -$18564.2 in Q1 2025, and down 3.81% on a QoQ basis from -$27726.0 in Q4 2025.
Tevogen (TVGN) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 4 years of Other Working Capital Changes data on file, last reported at -$28781.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 55.04% year-over-year to -$28781.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$262749.0 (down 2.43% YoY) and the FY2025 annual result came in at -$297976.0, down 17.91% from the prior year.
- Other Working Capital Changes declined to -$28781.0 in Q1 2026, from -$27726.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $500000.0 in Q4 2025 to a low of -$411025.0 in Q3 2024.
- A 5-year average of $71391.0 and a median of $24968.0 in 2025 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 58.54% in 2025, down 190.09% in 2025.
- Tracing TVGN's Other Working Capital Changes over 4 years: stood at -$61678.0 in 2023, then dropped by 7.35% to -$66214.0 in 2024, then soared by 58.13% to -$27726.0 in 2025, then retreated by 3.81% to -$28781.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$28781.0 (Q1 2026), -$27726.0 (Q4 2025), and -$26706.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tevogen | 25.62 Mn | 25.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 341,597.00 |
| Mar 31, 2026 | 341,597.00 |
| Mar 31, 2026 | 341,597.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | -307,720.00 |
| Sep 30, 2025 | -307,720.00 |
| Sep 30, 2025 | -307,720.00 |
| Jun 30, 2025 | 272,795.00 |
| Jun 30, 2025 | 272,795.00 |
| Jun 30, 2025 | 272,795.00 |
| Mar 31, 2025 | 24,968.00 |
| Mar 31, 2025 | 24,968.00 |
| Mar 31, 2025 | 24,968.00 |
| Dec 31, 2024 | 442,565.00 |
| Dec 31, 2024 | 442,565.00 |
| Dec 31, 2024 | 442,565.00 |
| Sep 30, 2024 | -411,025.00 |
| Sep 30, 2024 | -411,025.00 |